World's Best Scientists 2026 revealed!
Maria Pia Sormani

Maria Pia Sormani

D-Index & Metrics

Medicine

D-Index
110
Citations
43761
World Ranking
5577
National Ranking
176

Overview

Maria Pia Sormani is a researcher affiliated with the University of Genoa in Italy, specializing primarily in Medicine with a substantial focus on multiple sclerosis and related neurological conditions. Their work spans various subfields including Pathology and Forensic Medicine, Neurology, Oncology, Rheumatology, and Infectious Diseases.

Their research contributions cover multiple topics, with a significant emphasis on Multiple Sclerosis Research Studies. Other main areas of investigation include Polyomavirus and related diseases, Peripheral Neuropathies and Disorders, SARS-CoV-2 and COVID-19 Research, Rheumatoid Arthritis Research and Therapies, Long-Term Effects of COVID-19, and Systemic Lupus Erythematosus Research.

Recent papers authored or co-authored by Maria Pia Sormani include:

  • Multiple sclerosis progression: time for a new mechanism-driven framework, 2022, The Lancet Neurology
  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis, 2021, Annals of Neurology
  • Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia, 2020, European Journal of Internal Medicine
  • Neurofilaments as biomarkers in neurological disorders - towards clinical application, 2024, Nature Reviews Neurology
  • MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice, 2020, Nature Reviews Neurology

The researcher frequently publishes in journals such as Multiple Sclerosis Journal, Neurology, Multiple Sclerosis and Related Disorders, European Journal of Neurology, and JAMA Neurology.

Maria Pia Sormani collaborates regularly with a network of co-authors, including Irene Schiavetti, Alessio Signori, Francesca Bovis, Luca Carmisciano, and Marta Ponzano, reflecting an active participation in collaborative scientific efforts.

Best Publications

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Neurofilaments as biomarkers in neurological disorders

    Michael Khalil;Charlotte E. Teunissen;Markus Otto;Fredrik Piehl

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Classification criteria for autoinflammatory recurrent fevers

    Marco Gattorno;Michael Hofer;Silvia Federici;Federica Vanoni

  • Brain health: time matters in multiple sclerosis

    Gavin Giovannoni;Helmut Butzkueven;Suhayl Dhib-Jalbut;Jeremy Hobart

  • HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials

    Alessandra Gennari;Maria Pia Sormani;Paolo Pronzato;Matteo Puntoni

  • Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

    Mike P Wattjes;Àlex Rovira;David Miller;Tarek A. Yousry

  • Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.

    Maria Pia Sormani;Nicola De Rossi;Irene Schiavetti;Luca Carmisciano

  • Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis - Clinical implementation in the diagnostic process

    Àlex Rovira;Mike P. Wattjes;Mar Tintoré;Carmen Tur

  • Brain atrophy and lesion load predict long term disability in multiple sclerosis

    Veronica Popescu;Federica Agosta;Hanneke E Hulst;Ingrid C Sluimer

  • Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes.

    N. De Stefano;A. Giorgio;M. Battaglini;M. Rovaris

  • Glatiramer acetate reduces the proportion of new MS lesions evolving into "black holes".

    M. Filippi;M. Rovaris;M. A. Rocca;M. P. Sormani;M. P. Sormani

  • MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials

    Maria Pia Sormani;Paolo Bruzzi

  • Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

    Maria Pia Sormani;Douglas L. Arnold;Nicola De Stefano

  • Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical Event

    Darin T. Okuda;Aksel Siva;Orhun Kantarci;Matilde Inglese

  • Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis:

    Ludwig Kappos;Nicola De Stefano;Mark S. Freedman;Bruce A. C. C. Cree

  • Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers

    Silvia Federici;Maria Pia Sormani;Seza Ozen;Helen J Lachmann

  • Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial.

    Antonio Brucato;Massimo Imazio;Marco Gattorno;George Lazaros

  • Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis

    Nicola De Stefano;Maria Laura Stromillo;Antonio Giorgio;Maria Letizia Bartolozzi

  • Scoring treatment response in patients with relapsing multiple sclerosis.

    MP Sormani;J Rio;M Tintorè;A Signori

Frequent Co-Authors

Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University
Nicola De Stefano
Nicola De Stefano University of Siena
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Paolo Bruzzi
Paolo Bruzzi Ospedale San Martino
Frederik Barkhof
Frederik Barkhof University College London
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Maria A. Rocca
Maria A. Rocca Vita-Salute San Raffaele University
Marco Rovaris
Marco Rovaris University of Milan
Marco Gattorno
Marco Gattorno Istituto Giannina Gaslini

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine isn’t just limited to traditional medical degrees—there are many online options that can offer flexibility and affordability. For registered nurses looking to advance their qualifications, the cheapest rn to bsn online programs provide a cost-effective route to earning a Bachelor of Science in Nursing. These programs are designed for working professionals seeking career growth without extensive student debt.

If you hold a non-nursing undergraduate degree, direct entry msn programs for non-nursing majors can help you quickly transition into advanced nursing roles. Those searching for accessible entry points into nursing may also want to explore online bsn programs for non nurses, which typically feature more flexible admissions requirements.

Additionally, healthcare administration and support roles are in high demand. Consider medical billing and coding schools online for specialized training that can lead you to a career in the administrative side of medicine. Exploring these pathways can help you find the program that best matches your interests, schedule, and budget.

Best Scientists Citing Maria Pia Sormani

Trending Scientists

Recently Published Articles